Moberg Pharma (Sweden) Today
| MOB Stock | SEK 17.85 0.42 2.41% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Moberg Pharma is selling for under 17.85 as of the 2nd of December 2024; that is 2.41% up since the beginning of the trading day. The stock's last reported lowest price was 17.3. Moberg Pharma has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Moberg Pharma AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Moberg Pharma AB , a pharmaceutical company, develops and commercializes medical products for pain and skin conditions in Europe, the United States, and internationally. Moberg Pharma AB was incorporated in 2006 and is headquartered in Bromma, Sweden. The company has 98.27 M outstanding shares. More on Moberg Pharma AB
Moving against Moberg Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Moberg Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Moberg Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Moberg Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Moberg Pharma AB (MOB) is traded on Stockholm Exchange in Sweden and employs 7 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 272.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moberg Pharma's market, we take the total number of its shares issued and multiply it by Moberg Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Moberg Pharma AB operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 98.27 M outstanding shares.
Moberg Pharma AB has accumulated about 36.6 M in cash with (15.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.82.
Check Moberg Pharma Probability Of Bankruptcy
Ownership AllocationMoberg Pharma AB maintains a total of 98.27 Million outstanding shares. Moberg Pharma AB secures 18.07 % of its outstanding shares held by insiders and 3.39 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Moberg Ownership Details
Moberg Pharma AB Risk Profiles
Although Moberg Pharma's alpha and beta are two of the key measurements used to evaluate Moberg Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.28 | |||
| Standard Deviation | 8.71 | |||
| Variance | 75.85 | |||
| Risk Adjusted Performance | (0.02) |
Moberg Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Moberg Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Moberg Pharma Corporate Management
Elected by the shareholders, the Moberg Pharma's board of directors comprises two types of representatives: Moberg Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moberg. The board's role is to monitor Moberg Pharma's management team and ensure that shareholders' interests are well served. Moberg Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moberg Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Beveridge | VP Fin | Profile | |
| Anders Broijersen | Chief Officer | Profile | |
| MSc BA | Chief Officer | Profile | |
| Kerstin Strinnholm | Ex Chairman | Profile | |
| Marie Moberg | CoFounder | Profile | |
| Gunilla Wengstrm | Director Marketing | Profile |
Additional Tools for Moberg Stock Analysis
When running Moberg Pharma's price analysis, check to measure Moberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moberg Pharma is operating at the current time. Most of Moberg Pharma's value examination focuses on studying past and present price action to predict the probability of Moberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moberg Pharma's price. Additionally, you may evaluate how the addition of Moberg Pharma to your portfolios can decrease your overall portfolio volatility.